The goal of this clinical trial is to evaluate whether the application of optimized transcranial direct current stimulation is more effective compared to sham stimulation for temporary improvement of swallowing function in patients with post-stroke dysphagia.
men and women >19 years old
patients with stroke confirmed by neuroimaging
first-time stroke patients
patients in subacute or chronic phases of stroke with 3 weeks or more after onset
patients with recurrent stoke, traumatic brain injury, spine cord injury, and degenerative brain disease, such as Parkinson's disease, etc.
patients with deteriorated cognitive function unable to perform the clinical trial as instructed
patients with evidence of delirium, confusion, or other impairment of consciousness
patients with uncontrolled medical disease or surgical conditions
NEUROPHET
Lead sponsor
Bucheon St. Mary's Hospital
Collaborator
Saint Vincent's Hospital, Korea
Collaborator
National Traffic Injury Rehabilitation Hospital
Collaborator
Pusan National University Yangsan Hospital
Collaborator